To Evaluate the Safety/Tolerability and Pharmacokinetic Characteristics in Healthy Volunteers
ConditionHealthy
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age19-50
SponsorJW Pharmaceutical
About this trial
This clinical trial is a randomized, double-blind, placebo-controlled, single ascending dose, phase 1 clinical trial to evaluate the safety/tolerability and pharmacokinetic characteristics, and to explore food effect and ethnic difference of JW2286 after oral administration in healthy adults.
Eligibility criteria
Qualifiers
Healthy Korean or Caucasian volunteers
Disqualifiers
Individuals with a clinically significant disease or history
Individuals with a history of a gastrointestinal disorder or surgery
In the case of all female individuals with childbearing potential, except for those who are surgically sterile
Trial design
Treatments tested in this trial
- JW2286
- Placebo of JW2286
Treatment groups
72 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov